On December 15, 2016, Forest Laboratories LLC and its subsidiary, Forest Pharmaceuticals Inc., agreed to pay $38 to resolve allegations that Forest violated the Anti-Kickback Statute of the False Claims Act.  The government contends that Forest provided improper inducements to a group of physicians in the form of payments and meals in connection with speaker programs, and that these benefits were provided for speaker programs that were cancelled or not attended by any licensed healthcare professionals, among other things.  The settlement resolves a qui tam lawsuit brought by a former Forest employee, Kurt Kroening, who will received approximately $7.8 million of the total settlement.  U.S. ex rel. Kroening v. Forest Pharmaceuticals, Inc., et al., No. 12-CV-366 (E.D. Wis.) DOJ Press Release